Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Treatment of mental disorders of generative cycle in women

Full Text:


The clinical and etiological diversity of depressive, anxiety, dysmorphic and psychotic disorders of the generative cycle in women necessitates an integrated approach to evaluation and treatment methods.

During an individual approach to treatment administration, it is necessary to take into account the risk factors (heredity, comorbid disorders, gender, age, etc.) of adverse events, the spectrum of endocrine side effects characteristic of each drug, the balance of drug efficacy and safety.

The effectiveness of hormone replacement therapy, including in combination with “fortifying” drugs, vitamins, dietary supplements, physiotherapy, in mental disorders has not been proven.

Psychopharmacotherapy should include modern antidepressants, anxiolytics, antipsychotics with an emphasis on good tolerance, a minimum of adverse events, compatibility with hormonal therapy, and ease of dosing.

Psychotherapy, psychological support and psycho-correction can reduce the severity of anxiety and depressive symptoms and significantly increase the treatment effectiveness.

About the Author

V. E. Medvedev
Peoples' Friendship University of Russia (RUDN University)
Russian Federation

Vladimir Ernstovich Medvedev

6, Miklukho-Maklai St., Moscow 117198, Russia


1. Tyuvina NA, Voronina EO, Balabanova VV, Goncharova EM. The relationship and interaction of menstrual and generative function and depressive disorders in women. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(2):45-51. doi: 10.14412/2074-2711-2018-2-45-51 (In Russ.).

2. Tyuvina NA, Balabanova VV, Voronina EO. Gender features of depressive disorders in women. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2015;7(2):75-9. doi: 10.14412/2074-2711-2015-2-75-79 (In Russ.).

3. Halbreich U, Kahn LS. Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes? J Affect Disord. 2007 Sep;102(1-3):245-58. doi: 10.1016/j.jad.2006.09.023. Epub 2006 Nov 7.

4. Khan AA, Gardner CO, Prescott CA, Kendler KS. Gender differences in the symptoms of major depression in opposite-sex dizygotic twin pairs. Am J Psychiatry. 2002 Aug;159(8):1427-9. doi: 10.1176/appi.ajp.159.8.1427

5. Lai CH. Major depressive disorder: gender differences in symptoms, life quality, and sexual function. J Clin Psychopharmacol. 2011 Feb;31(1):39-44. doi: 10.1097/JCP.0b013e318205a670

6. Levitan RD, Lesage A, Parikh SV, et al. Reversed neurovegetative symptoms of depression: a community study of Ontario. Am J Psychiatry. 1997 Jul;154(7):934-40. doi: 10.1176/ajp.154.7.934

7. Moskvina V, Farmer A, Jones IR, et al. Sex differences in symptom patterns of recurrent major depression in siblings. Depress Anxiety. 2008;25(6):527-34. doi: 10.1002/da.20372

8. Seeman MV. Psychopathology in women and men: focus on female hormones. Am J Psychiatry. 1997 Dec;154(12):1641-7. doi: 10.1176/ajp.154.12.1641

9. Silverstein B. Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms. Am J Psychiatry. 1999 Mar;156(3):480-2. doi: 10.1176/ajp.156.3.480

10. Silverstein B, Edwards T, Gamma A, et al. The role played by depression associated with somatic symptomatology in accounting for the gender difference in the prevalence of depression. Soc Psychiatry Psychiatr Epidemiol. 2013 Feb;48(2):257-63. doi: 10.1007/s00127-012-0540-7. Epub 2012 Jul 3.

11. Dementieva NO, Bocharov VV. Psychological aspects of the study of female infertility of “unclear etiology”. Vestnik SPbGU. Ser. 12 = Bulletin of St. Petersburg State University. Ser. 12. 2010 Dec;(1):131-9 (In Russ.).

12. Rooney KL, Domar AD. The relationship between stress and infertility. Dialogues Clin Neurosci. 2018 Mar;20(1):41-7. doi: 10.31887/DCNS.2018.20.1/klrooney

13. Karimzadeh M, Rostami M, Teymouri R, et al. The association between parental mental health and behavioral disorders in pre-school children. Electron Physician. 2017 Jun 25;9(6):4497-502. doi: 10.19082/4497. eCollection 2017 Jun.

14. Worsley R, Davis SR, Gavrilidis E, et al. Hormonal therapies for new onset and relapsed depression during perimenopause. Maturitas. 2012 Oct;73(2):127-33. doi: 10.1016/j.maturitas.2012.06.011. Epub 2012 Jul 22.

15. Medvedev VE. Dysmorphic disorders: clinical and nosological heterogeneity. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;(8)1:49-55. doi: 10.14412/2074-2711-2016-1-49-55 (In Russ.).

16. Medvedev VE, Frolova VI, Martynov SE, Vissarionov VA. Dysmorphic disorder in the structure of mental disorders in patients of a plastic surgeon and cosmetologist. Psikhicheskoye zdorov'ye. 2017;(2):48-55 (In Russ.).

17. Medvedev VE, Frolova VI, Avdoshenko KE, et al. Pathocharacterological and pathopsychological disorders in patients of a plastic surgeon and cosmetologist. Eksperimental'naya i klinicheskaya dermatokosmetologiya. 2012;(3):60-4 (In Russ.).

18. Medvedev VE, Frolova VI, Gushanskaya EV, et al. Depressions with eating disorders: clinical manifestations and therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):49-56. doi: 10.14412/2074-2711-2020-4-49-56 (In Russ.).

19. Medvedev VE, Frolova VI, Martynov SE, Vissarionov VA. Mental disorders with unreasonable dissatisfaction with their own appearance in patients of a plastic surgeon and cosmetologist. Psikhiatriya i psikhofarmakoterapiya = Psychiatry and Psychopharmacotherapy. 2016;(6):49-54 (In Russ.).

20. Fofanova YuS, Medvedev VE, Frolova VI. Psychosomatic aspects of atypical prosopalgia. Psikhicheskoye zdorov'ye. 2015;(9):43-9 (In Russ.).

21. Kraepelin E. Zur Entartungsfrage. Zentralblatt für Nervenheilkunde und Psychiatrie. 1908;31(Neue Folge 19):745-51.

22. Volel' BA, Yan'shina TP. Involutionary hysteria within the dynamics of personality disorders. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2004;(11):47-54 (In Russ.).

23. Gilyarovskiy VA. Psikhiatriya [Psychiatry]. Moscow: Medgiz; 1954 (In Russ.).

24. Geyer TA. To the formulation of the question of “involutionary hysteria”. Trudy psikhiatricheskoy kliniki I Moskovskogo universiteta. 1927;(2):45-51 (In Russ.).

25. Bumke О. Lehrubuch des Geisteskrankheiter. 1924. P. 438-56.

26. Horackova H, Karahoda R, Cerveny L, et al. Effect of Selected Antidepressants on Placental Homeostasis of Serotonin: Maternal and Fetal Perspectives. Pharmaceutics. 2021 Aug 20;13(8):1306. doi: 10.3390/pharmaceutics13081306

27. Al-Fadel N, Alrwisan A. Antidepressant Use During Pregnancy and the Potential Risks of Motor Outcomes and Intellectual Disabilities in Offspring: A Systematic Review. Drugs Real World Outcomes. 2021 Jun;8(2):105-23. doi: 10.1007/s40801-021-00232-z. Epub 2021 Feb 12.

28. Cooper WO, Willy ME, Pont SJ, Ray WA. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol. 2007 Jun;196(6):544.e1-5. doi: 10.1016/j.ajog.2007.01.033

29. Alwan S, Reefhuis J, Rasmussen SA, Friedman JM. National Birth Defects Prevention Study. Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol. 2011 Feb;51(2):264-70. doi: 10.1177/0091270010373928. Epub 2010 Jul 27.

30. Petersen I, Gilbert RE, Evans SJ, et al. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry. 2011 Jul;72(7):979-85. doi: 10.4088/JCP.10m06090blu. Epub 2011 Mar 8.

31. Roca A, Imaz ML, Torres A, et al. Unplanned pregnancy and discontinuation of SSRIs in pregnant women with previously treated affective disorder. J Affect Disord. 2013 Sep 25;150(3):807-13. doi: 10.1016/j.jad.2013.02.040. Epub 2013 Apr 6.

32. Manchenko DM, Glazova NYu, Levitskaya NG. Experimental studies of the effects of prenatal use of serotonin reuptake inhibitors. In: Kostyuk GP, editor. Materialy nauchno-prakticheskoy konferentsii (29 oktyabrya 2018 g., Moskva) [Materials of the scientific and practical conference (October 29, 2018, Moscow)]. Moscow: KDU – University book; 2019. P. 636-44 (In Russ.).

33. El Marroun H, Jaddoe VW, Hudziak JJ, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry. 2012 Jul;69(7):706-14. doi: 10.1001/archgenpsychiatry.2011.2333

34. Marachev MP. Features of psychopharmacotherapy during pregnancy and lactation. Psikhiatriya i psikhofarmakoterapiya = Psychiatry and Psychopharmacotherapy. 2018;(3-4):34-42 (In Russ.).

35. Barnes TRE. Schizophrenia Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2011 May;25(5):567-620. doi: 10.1177/0269881110391123. Epub 2011 Feb 3.

36. Boden R, Lundgren M, Brandt L, et al. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry. 2012 Jul;69(7):715-21. doi: 10.1001/archgenpsychiatry.2011.1870

37. HAPO Study Cooperative Research Group. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG. 2010 Apr;117(5):575-84. doi: 10.1111/j.1471-0528.2009.02486.x. Epub 2010 Jan 20.

38. Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes – a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012 Mar 31;12:23. doi: 10.1186/1471-2393-12-23

39. Sörensen MJ, Kjaersgaard MI, Pedersen HS, et al. Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy. PLoS One. 2015 Jul 10;10(7):e0132280. doi: 10.1371/journal.pone.0132280

40. Hale GE, Robertson DM, Burger HG. The perimenopausal woman: endocrinology and management. J Steroid Biochem Mol Biol. 2014 Jul;142:121-31. doi: 10.1016/j.jsbmb.2013.08.015

41. Tripathi BM, Majumder P. Lactating mother and psychotropic drugs. Mens Sana Monogr. 2010 Jan;8(1):83-95. doi: 10.4103/0973-1229.58821

42. World Health Organization. Global strategy for infant and young child feeding. Geneva; 2003.

43. Dubnitskaya EB. Non-psychotic depressions associated with the reproductive aging of women (lecture). Psikhicheskiye rasstroystva v obshchey meditsine. 2010;(4):18-21 (In Russ.).

44. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol. 1992 Jul;80(1):30-6.

45. Yureneva SV, Il'ina LM, Yakushevskaya OV. Postmenopausal menopausal hormone therapy: quality of life today and in the long term. Ginekologiya. 2016;18(1):24-9 (In Russ.).

46. Stearns V, Loprinzi CL. New therapeutic approaches for hot flashes in women. J Support Oncol. May-Jun 2003;1(1):11-21; discussion 14-5, 19-21.

47. Freeman EW. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder. CNS Drugs. 2004;18(7):453-68. doi: 10.2165/00023210-200418070-00004

48. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry. 2005 Jun;66(6):774-80. doi: 10.4088/jcp.v66n0617

49. Anisimov VN, Vinogradova IA. Stareniye zhenskoy reproduktivnoy sistemy i melatonin [Aging of the female reproductive system and melatonin]. St. Petersburg: Sistema; 2008. 44 p. (In Russ.).

50. Joffe H. Reproductive biology and psychotropic treatments in premenopausal women with bipolar disorder. J Clin Psychiatry. 2007;68 Suppl 9:10-5.

51. Soares CN, Poitras JR, Prouty J. Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging. 2003;20(2):85-100. doi: 10.2165/00002512-200320020-00001

52. Richards JB, Papaioannou A, Adachi JD, et al. Canadian Multicentre Osteoporosis Study Research Group. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007 Jan 22;167(2):188-94. doi: 10.1001/archinte.167.2.188

53. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry. 2001;62(Suppl 3):10-21.

54. Mazo GE, Ganzenko MA. Depression in women during the menopausal transition. Psikhiatriya i psikhofarmakoterapiya = Psychiatry and Psychopharmacotherapy. 2016;18(6):30-6 (In Russ.).

55. Azarbad L, Gonder-Frederick L. Obesity in women. Psychiatr Clin North Am. 2010 Jun;33(2):423-40. doi: 10.1016/j.psc.2010.01.003

56. Medvedev V. Treatment of non-psychotic depressions in the framework of involutional hysteria (experience of Valdoxan use). Psikhiatriya i psikhofarmakoterapiya = Psychiatry and Psychopharmacotherapy. 2011;42(4):14-8 (In Russ.).

57. Solov'yeva IK. Afobazole in therapeutic practice. RMZh. 2006;29:2075 (In Russ.).

58. Mkrtchyan VR. Terapevticheskiye vozmozhnosti adaptola v lechenii vegetativnykh narusheniy u zhenshchin [Therapeutic possibilities of adaptol in the treatment of autonomic disorders in women.]. Kyiv; 2012 (In Russ.).

59. Semenkova GG, Matvienko EE. Correction of psycho-autonomic disorders in women with arterial hypertension during postmenopausal period. Ratsional'naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2009;5(2):70-4. doi: 10.20996/1819-6446-2009-5-2-70-74 (In Russ.).

60. Shishkova VN, Zotova LI. The use of D-, L-hopantenic acid in the treatment of cognitive and anxiety disorders in women with chronic cerebral ischemia and menopausal syndrome. RMZh. 2015;24:1470-5 (In Russ.).

61. Medvedev VE. Psychopathological aspects of involutional hysteria. Consilium Medicum. 2012;14(6):26-9 (In Russ.).

62. Berle JO, Spigset O. Antidepressant Use During Breastfeeding. Curr Womens Health Rev. 2011 Feb;7(1):28-34. doi: 10.2174/157340411794474784

63. Van Batenburg-Eddes T, Brion MJ, Henrichs J, et al. Parental depressive and anxiety symptoms during pregnancy and attention problems in children: a cross-cohort consistency study. J Child Psychol Psychiatry. 2013 May;54(5):591-600. doi: 10.1111/jcpp.12023 . Epub 2012 Dec 7.


For citations:

Medvedev V.E. Treatment of mental disorders of generative cycle in women. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(2):84-90. (In Russ.)

Views: 123

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)